Cargando…

FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor

Assessment of T-cell response to the tumor is important for diagnosis of the disease and monitoring of therapeutic efficacy. For this, new non-destructive label-free methods are required. Fluorescence lifetime imaging (FLIM) of metabolic coenzymes is a promising innovative technology for the assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Izosimova, Anna V., Shirmanova, Marina V., Shcheslavskiy, Vladislav I., Sachkova, Daria A., Mozherov, Artem M., Sharonov, George V., Zagaynova, Elena V., Yuzhakova, Diana V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779489/
https://www.ncbi.nlm.nih.gov/pubmed/36555468
http://dx.doi.org/10.3390/ijms232415829
_version_ 1784856622147829760
author Izosimova, Anna V.
Shirmanova, Marina V.
Shcheslavskiy, Vladislav I.
Sachkova, Daria A.
Mozherov, Artem M.
Sharonov, George V.
Zagaynova, Elena V.
Yuzhakova, Diana V.
author_facet Izosimova, Anna V.
Shirmanova, Marina V.
Shcheslavskiy, Vladislav I.
Sachkova, Daria A.
Mozherov, Artem M.
Sharonov, George V.
Zagaynova, Elena V.
Yuzhakova, Diana V.
author_sort Izosimova, Anna V.
collection PubMed
description Assessment of T-cell response to the tumor is important for diagnosis of the disease and monitoring of therapeutic efficacy. For this, new non-destructive label-free methods are required. Fluorescence lifetime imaging (FLIM) of metabolic coenzymes is a promising innovative technology for the assessment of the functional status of cells. The purpose of this work was to test whether FLIM can resolve metabolic alterations that accompany T-cell reactivation to the tumors. The study was carried out on C57Bl/6 FoxP3-EGFP mice bearing B16F0 melanoma. Autofluorescence of the immune cells in fresh lymphatic nodes (LNs) was investigated. It was found that fluorescence lifetime parameters of nicotinamide adenine dinucleotide (phosphate) NAD(P)H are sensitive to tumor development. Effector T-cells in the LNs displayed higher contribution of free NADH, the form associated with glycolysis, in all tumors and the presence of protein-bound NADPH, associated with biosynthetic processes, in the tumors of large size. Flow cytometry showed that the changes in the NADH fraction of the effector T-cells correlated with their activation, while changes in NADPH correlated with cell proliferation. In conclusion, FLIM of NAD(P)H in fresh lymphoid tissue is a powerful tool for assessing the immune response to tumor development.
format Online
Article
Text
id pubmed-9779489
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97794892022-12-23 FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor Izosimova, Anna V. Shirmanova, Marina V. Shcheslavskiy, Vladislav I. Sachkova, Daria A. Mozherov, Artem M. Sharonov, George V. Zagaynova, Elena V. Yuzhakova, Diana V. Int J Mol Sci Article Assessment of T-cell response to the tumor is important for diagnosis of the disease and monitoring of therapeutic efficacy. For this, new non-destructive label-free methods are required. Fluorescence lifetime imaging (FLIM) of metabolic coenzymes is a promising innovative technology for the assessment of the functional status of cells. The purpose of this work was to test whether FLIM can resolve metabolic alterations that accompany T-cell reactivation to the tumors. The study was carried out on C57Bl/6 FoxP3-EGFP mice bearing B16F0 melanoma. Autofluorescence of the immune cells in fresh lymphatic nodes (LNs) was investigated. It was found that fluorescence lifetime parameters of nicotinamide adenine dinucleotide (phosphate) NAD(P)H are sensitive to tumor development. Effector T-cells in the LNs displayed higher contribution of free NADH, the form associated with glycolysis, in all tumors and the presence of protein-bound NADPH, associated with biosynthetic processes, in the tumors of large size. Flow cytometry showed that the changes in the NADH fraction of the effector T-cells correlated with their activation, while changes in NADPH correlated with cell proliferation. In conclusion, FLIM of NAD(P)H in fresh lymphoid tissue is a powerful tool for assessing the immune response to tumor development. MDPI 2022-12-13 /pmc/articles/PMC9779489/ /pubmed/36555468 http://dx.doi.org/10.3390/ijms232415829 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Izosimova, Anna V.
Shirmanova, Marina V.
Shcheslavskiy, Vladislav I.
Sachkova, Daria A.
Mozherov, Artem M.
Sharonov, George V.
Zagaynova, Elena V.
Yuzhakova, Diana V.
FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
title FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
title_full FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
title_fullStr FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
title_full_unstemmed FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
title_short FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
title_sort flim of nad(p)h in lymphatic nodes resolves t-cell immune response to the tumor
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779489/
https://www.ncbi.nlm.nih.gov/pubmed/36555468
http://dx.doi.org/10.3390/ijms232415829
work_keys_str_mv AT izosimovaannav flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT shirmanovamarinav flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT shcheslavskiyvladislavi flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT sachkovadariaa flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT mozherovartemm flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT sharonovgeorgev flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT zagaynovaelenav flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor
AT yuzhakovadianav flimofnadphinlymphaticnodesresolvestcellimmuneresponsetothetumor